AMGEN INC
AMGNAPI behind this page
AMGN Q3 2025 request
Playground key active
/api/financials?ticker=AMGN&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 9,557 | 8,503 | +12.4% |
Show Product Lines breakouts |
|||
| Aranesp | 357 | 337 | +5.9% |
| Aranesp · Non Us | 254 | 232 | +9.5% |
| Aranesp · US | 103 | 105 | -1.9% |
| BLINCYTO | 392 | 327 | +19.9% |
| BLINCYTO · Non Us | 156 | 90 | +73.3% |
| BLINCYTO · US | 236 | 237 | -0.4% |
| ENBREL | 580 | 825 | -29.7% |
| ENBREL · Non Us | 6 | 8 | -25.0% |
| ENBREL · US | 574 | 817 | -29.7% |
| EVENITY | 541 | 399 | +35.6% |
| EVENITY · Non Us | 124 | 110 | +12.7% |
| EVENITY · US | 417 | 289 | +44.3% |
| KRYSTEXXA | 320 | 310 | +3.2% |
| KRYSTEXXA · US | 320 | 310 | +3.2% |
| KYPROLIS | 359 | 378 | -5.0% |
| KYPROLIS · Non Us | 134 | 140 | -4.3% |
| KYPROLIS · US | 225 | 238 | -5.5% |
| Nplate [Member] | 457 | 456 | +0.2% |
| Nplate [Member] · Non Us | 124 | 111 | +11.7% |
| Nplate [Member] · US | 333 | 345 | -3.5% |
| Otezla | 585 | 564 | +3.7% |
| Otezla · Non Us | 112 | 104 | +7.7% |
| Otezla · US | 473 | 460 | +2.8% |
| Other products | 1,853 | 1,363 | +36.0% |
| Other products · Non Us | 445 | 405 | +9.9% |
| Other products · US | 1,408 | 958 | +47.0% |
| Product | 9,137 | 8,151 | +12.1% |
| Product And Service Other | 420 | 352 | +19.3% |
| Product And Service Other · Reportable Segment | 420 | 352 | +19.3% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | -28 | 45 | -162.2% |
| Product · Accumulated Gain Loss Net Cash Flow Hedge Parent | -28 | 45 | -162.2% |
| Product · Non Us | 2,386 | 2,172 | +9.9% |
| Product · Reportable Segment | 9,137 | 8,151 | +12.1% |
| Product · US | 6,751 | 5,979 | +12.9% |
| Prolia | 1,139 | 1,045 | +9.0% |
| Prolia · Non Us | 333 | 362 | -8.0% |
| Prolia · US | 806 | 683 | +18.0% |
| Repatha | 794 | 567 | +40.0% |
| Repatha · Non Us | 352 | 286 | +23.1% |
| Repatha · US | 442 | 281 | +57.3% |
| TEPEZZA | 560 | 488 | +14.8% |
| TEPEZZA · Non Us | 42 | 6 | +600.0% |
| TEPEZZA · US | 518 | 482 | +7.5% |
| TEZSPIRE | 377 | 269 | +40.1% |
| TEZSPIRE · US | 377 | 269 | +40.1% |
| Vectibix | 284 | 282 | +0.7% |
| Vectibix · Non Us | 122 | 150 | -18.7% |
| Vectibix · US | 162 | 132 | +22.7% |
| XGEVA | 539 | 541 | -0.4% |
| XGEVA · Non Us | 182 | 168 | +8.3% |
| XGEVA · US | 357 | 373 | -4.3% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 9,557 | 8,503 | +12.4% |
| Cost of Revenue | 3,082 | 3,310 | -6.9% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 2,508 | 2,852 | -12.1% |
| Research And Development Expense Excluding Acquired In Process Cost | 1,900 | 1,450 | +31.0% |
| Selling, General & Administrative | 1,720 | 1,625 | +5.8% |
| Other General Expense | 329 | 71 | +363.4% |
| Total Costs & Expenses | 7,031 | 6,456 | +8.9% |
| Operating Income | 2,526 | 2,047 | +23.4% |
| Interest Expense Debt | -685 | -776 | +11.7% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | -685 | -776 | +11.7% |
| Non-Operating Income (Expense) | 2,080 | 1,830 | +13.7% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contracts | -39 | 121 | -132.2% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Cross-currency swap contracts | -39 | 121 | -132.2% |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | 3,921 | 3,101 | +26.4% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -67 | 166 | -140.4% |
| Income Tax Expense (Benefit) | 705 | 271 | +160.1% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 705 | 271 | +160.1% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -14 | 36 | -138.9% |
| Net Income | 3,216 | 2,830 | +13.6% |
Show Business Segments breakouts |
|||
| Reportable Segment | 3,216 | 2,830 | +13.6% |
| Reportable Segment · Operating Segments | 3,216 | 2,830 | +13.6% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income | -53 | 130 | -140.8% |
| Retained Earnings | 3,216 | 2,830 | +13.6% |
| EPS (Basic) | 5.98 | 5.27 | +13.5% |
| EPS (Diluted) | 5.93 | 5.22 | +13.6% |
| Wtd Avg Shares (Basic) | 538 | 537 | +0.2% |
| Wtd Avg Shares (Diluted) | 542 | 542 | 0.0% |
| Sales & Marketing (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 1,097 | 1,117 | -1.8% |
| General & Administrative (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 623 | 508 | +22.6% |
| Interest Income | 99 | 126 | -21.4% |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | 99 | 126 | -21.4% |
| Comprehensive Income | 3,338 | 2,649 | +26.0% |
| Other Comprehensive Income | 122 | -181 | +167.4% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 122 | -181 | +167.4% |
| Depreciation And Amortization | 232 | 198 | +17.2% |
| Income Loss From Equity Method Investments (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment · Operating Segments | -10 | 28 | -135.7% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 9,445 | 9,011 | +4.8% |
| Accounts Receivable | 8,490 | 7,317 | +16.0% |
| Inventory | 6,346 | 7,362 | -13.8% |
| Other Assets Current | 3,604 | 3,076 | +17.2% |
| Total Current Assets | 27,885 | 26,766 | +4.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 7,220 | 6,156 | +17.3% |
| Goodwill | 18,676 | — | — |
| Other Non-Current Assets | 13,221 | 10,383 | +27.3% |
| Total Assets | 90,141 | 90,883 | -0.8% |
| Intangible Assets | 22,429 | — | — |
Show Product Lines breakouts |
|||
| Otezla · Developed Technology Rights | 3.4 | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Developed Technology Rights | 21,919 | — | — |
| Licensing Agreements | 385 | — | — |
| Research and development technology rights | 125 | — | — |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 23,139 | — | — |
| Current Liabilities | |||
| Accounts Payable | 2,838 | 2,147 | +32.2% |
| Accrued Liabilities | 16,800 | 14,621 | +14.9% |
| Current Portion of Long-Term Debt | 2,153 | 3,544 | -39.2% |
| Total Current Liabilities | 21,791 | 20,312 | +7.3% |
| Non-Current Liabilities | |||
| Long-Term Debt | 52,434 | 56,854 | -7.8% |
| Deferred Tax Liabilities | 1,458 | 1,711 | -14.8% |
| Liability For Uncertain Tax Positions Noncurrent | 2,616 | 2,280 | +14.7% |
| Other Non-Current Liabilities | 2,223 | 2,199 | +1.1% |
| Long-Term Debt | 54,587 | 60,398 | -9.6% |
Show Long-Term Debt Type breakouts |
|||
| Notes Payable To Banks | 52.8 | 58.6 | -9.9% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 33,841 | 33,393 | +1.3% |
| Retained Earnings | -23,800 | -25,530 | +6.8% |
| Accumulated Other Comprehensive Income | -422 | -336 | -25.6% |
| Total Stockholders' Equity | 9,619 | 7,527 | +27.8% |
Show Equity Components breakouts |
|||
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -225 | — | — |
| Accumulated Other Comprehensive Income | -422 | -336 | -25.6% |
| Accumulated Translation Adjustment | -220 | — | — |
| Common Stock Including Additional Paid In Capital | 33,841 | 33,393 | +1.3% |
| Other | 23 | — | — |
| Retained Earnings | -23,800 | -25,530 | +6.8% |
| Total Liabilities & Equity | 90,141 | 90,883 | -0.8% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 4,035 | 4,195 | -3.8% |
| Impairment Of Intangible Assets Excluding Goodwill | 1,200 | 129 | +830.2% |
| Stock-Based Compensation | 369 | 396 | -6.8% |
| Deferred Income Taxes And Tax Credits | -702 | -894 | +21.5% |
| Unrealized Gain Loss On Investments | -2,712 | -717 | -278.2% |
| Other Non-Cash Items | -101 | -139 | +27.3% |
| Change in Accounts Receivable | -1,601 | -32 | -4903.1% |
| Change in Inventory | 767 | 2,209 | -65.3% |
| Increase Decrease In Other Operating Assets | -690 | -638 | -8.2% |
| Change in Accounts Payable | 912 | 544 | +67.6% |
| Increase Decrease In Accrued Income Taxes Payable | -1,703 | -1,064 | -60.1% |
| Increase Decrease In Noncurrent Tax Liability | 236 | -561 | +142.1% |
| Increase Decrease In Accrued Liabilities | -250 | -636 | +60.7% |
| Increase Decrease In Sales Incentives And Allowance | 2,297 | 536 | +328.5% |
| Increase Decrease In Other Operating Liabilities | -80 | -72 | -11.1% |
| Net Cash from Operations | 8,355 | 6,719 | +24.3% |
| Investing Activities | |||
| Capital Expenditures | -1,216 | -725 | -67.7% |
| Other Investing Activities | -34 | 81 | -142.0% |
| Net Cash from Investing | -1,250 | -644 | -94.1% |
| Financing Activities | |||
| Payments Of Debt Extinguishment Costs | -683 | -659 | -3.6% |
| Repayments Of Long Term Debt | -5,000 | -3,600 | -38.9% |
Show Debt Instrument breakouts |
|||
| Various Long-Term Notes · Notes Payable To Banks | -1 | -875 | +99.9% |
| Payments Of Dividends Common Stock | -3,841 | -3,627 | -5.9% |
| Proceeds From Payments For Other Financing Activities | -109 | -122 | +10.7% |
| Net Cash from Financing | -9,633 | -8,008 | -20.3% |
| Other Cash Flow | |||
| Net Change in Cash | -2,528 | -1,933 | -30.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9,445 | 9,011 | +4.8% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.